
Dalton Transactions p. 1667 - 1674 (2006)
Update date:2022-08-04
Topics:
Brown, Michael D.
Levason, William
Reid, Gillian
Webster, Michael
The planar Pt(II) monomers [PtMe2(L-L)] and [(PtMe 2)2(L′-L′)2] dimers (L-L = R 2Sb(CH2)3SbR2, o-C6H 4(CH2SbMe2)2; L′-L′ = R2SbCH2SbR2; R = Me or Ph) are obtained in good yield via reaction of [PtMe2(SMe2)2] with L-L or L′-L′ in benzene. The Pt(iv) stibines, [PtMe3(L-L)I] (L-L = R2Sb(CH2)3SbR2, o-C 6H4(CH2SbMe2)2 or 2 × SbPh3, SbMePh2 or SbMe2Ph) are obtained by treatment of [PtMe3I] with L-L in chloroform. These represent the first series of stable Pt(iv) stibine complexes. All of the products have been characterised by 1H, 13C{1H}, 195Pt NMR spectroscopy, electrospray mass spectrometry and analysis. Crystal structure determinations on [PtMe3{R2Sb(CH2) 3SbR2}I], [PtMe3{o-C6H 4(CH2SbMe2)2}I] and [PtMe 3(SbPh3)2I] confirm the distorted octahedral environment at Pt, with fac Me groups and mutually cis Sb donor atoms. The Sb-Pt-Sb angle in the seven-membered chelate ring of the o-C6H 4(CH2SbMe2)2 complex is ca. 96°, compared to <90°in the complexes with six-membered chelates. The C 1-distibines R2SbCH2SbR2 afford only the dinuclear [(PtMe3)2(μ-R2SbCH 2SbR2)(μ-I)2] in which the stibine ligand and two I atoms bridge two Pt atoms giving an edge sharing bioctahedral geometry which has been confirmed by a crystal structure analysis. The Pt(ii) species undergo oxidative addition with MeI to give the corresponding Pt(iv) species, while the Pt(iv) species reductively eliminate ethane upon thermolysis. The Royal Society of Chemistry 2006.
Shanghai Forever Synthesis Co.,Ltd.
Contact:021-61124658
Address:Zhoukang Road,Pudong New District,Shanghai,China
Contact:86-574-26865651
Address:529 YuanBaoShan Road, Beilun District
hangzhou verychem science and technology co.ltd
website:http://www.verypharm.com
Contact:+86-571-88162785; 88162786
Address:F1502, 753 Shenhua road, Hangzhou, China
Shenzhen JYMed Technology Co.,Ltd.
website:http://www.jymedtech.com
Contact:+86-755-26612112
Address:1#8,9/F, Biomedicine innovation Industrial Park, No.14, Jinhui Road, Pingshan Sistrict, Shenzhen, China
Contact:0086-22-23410962
Address:17-201, Ningfuli, Shuishanggongyuandong road,Nankai district, Tianjin, China
Doi:10.1002/anie.201506505
(2015)Doi:10.1021/acs.orglett.9b04151
(2019)Doi:10.3390/molecules24061023
(2019)Doi:10.1016/j.tetasy.2006.07.036
(2006)Doi:10.1007/BF00515371
(1983)Doi:10.1016/0008-6215(91)84087-U
(1991)